Abstract
Neurocysticercosis is one of the most frequent parasitic diseases affecting the central nervous system. The introduction of anticysticidal therapy in the early 80s and the concomitant improvement of the radiological techniques have lead to apparently significant progress in patient prognosis. However, due to the specificity of the disease, a great debate has been generated on the real usefulness of cysticidal drugs. This article revises and discusses the pharmacological aspects of cysticidal treatment and summarizes current indications for the different types of the disease.
Keywords: Neurocysticercosis, taenia solium, treatment, albendazole, praziquantel, corticosteroids
Current Topics in Medicinal Chemistry
Title: Medical Treatment for Neurocysticercosis: Drugs, Indications and Perspectives
Volume: 8 Issue: 5
Author(s): Agnes Fleury, Helgi Jung, Graciela Cardenas and Edda Sciutto
Affiliation:
Keywords: Neurocysticercosis, taenia solium, treatment, albendazole, praziquantel, corticosteroids
Abstract: Neurocysticercosis is one of the most frequent parasitic diseases affecting the central nervous system. The introduction of anticysticidal therapy in the early 80s and the concomitant improvement of the radiological techniques have lead to apparently significant progress in patient prognosis. However, due to the specificity of the disease, a great debate has been generated on the real usefulness of cysticidal drugs. This article revises and discusses the pharmacological aspects of cysticidal treatment and summarizes current indications for the different types of the disease.
Export Options
About this article
Cite this article as:
Fleury Agnes, Jung Helgi, Cardenas Graciela and Sciutto Edda, Medical Treatment for Neurocysticercosis: Drugs, Indications and Perspectives, Current Topics in Medicinal Chemistry 2008; 8 (5) . https://dx.doi.org/10.2174/156802608783790811
DOI https://dx.doi.org/10.2174/156802608783790811 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Impact of Macrophages in Atherosclerosis
Current Medicinal Chemistry (Section B: Integrated Function of Drug Transporters In Vivo) Drug Transport at the Blood-Brain Barrier and the Choroid Plexus
Current Drug Metabolism Editorial: MRI of the Small Bowel
Current Medical Imaging Multidrug-Resistance (MDR) Proteins Develops Refractory Epilepsy Phenotype:Clinical and Experimental Evidences
Current Drug Therapy Natural Products and Cancer Stem Cells
Current Pharmaceutical Design Update on Pharmacologic Retinal Vascular Toxicity
Current Pharmaceutical Design Dealing with the Substance Abuse Epidemic and Infective Endocarditis:Clinical, Immunologic and Pathogenetic Aspects
Current Vascular Pharmacology Outcomes of Anticoagulant Therapy with Low-Molecular-Weight Heparin (LMWH) and Warfarin for Thromboangiitis Obliterans (TAO)
Current Vascular Pharmacology Catatonia Due to a General Medical Condition (Organic Catatonia)
Current Psychiatry Reviews Characterization of the Clinical and Laboratory Features of Primary and Secondary Antiphospholipid Syndrome in a Cohort of Egyptian Patients
Current Rheumatology Reviews Preterm Birth: Long Term Cardiovascular and Renal Consequences
Current Pediatric Reviews The Rapidly Changing Composition of the Global Street Drug Supply and its Effects on High-risk Groups for COVID-19
Current Psychopharmacology The Immune Protective Effect of the Mediterranean Diet against Chronic Low-grade Inflammatory Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Choosing between Targeted Therapies for Rheumatoid Arthritis Patients: The Oncology Perspective
Current Rheumatology Reviews The Relationship between Inflammatory and Oxidative Stress Biomarkers, Atherosclerosis and Rheumatic Diseases
Current Pharmaceutical Design Cyclophosphamide: Time to Say Goodnight and Goodbye?
Current Rheumatology Reviews Rheumatoid Arthritis: Notable Biomarkers Linking to Chronic Systemic Conditions and Cancer
Current Pharmaceutical Design Multiple Roles of the Extracellular Matrix in Inflammation
Current Pharmaceutical Design Clopidogrel and Aspirin in Cardiovascular Medicine: Responders or Not -- Current Best Available Evidence
Cardiovascular & Hematological Agents in Medicinal Chemistry An Update on Autoinflammatory Diseases
Current Medicinal Chemistry